Cyclin C/Cdk3 promotes Rb-dependent G0 exit

Cell

Volumn 117, Issue 2, 2004, Pages 239-251

  Ren, Shengjun ^a   Rollins, Barrett J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN C; CYCLIN DEPENDENT KINASE 3; CYCLINE; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

EID: 1942421702     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(04)00300-9     Document Type: Article

References (48)

1. Akoulitchev S., Chuikov S., Reinberg D. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature. 407:2000;102-106.
2. Brantley M.A. Jr., Harbour J.W. Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region. Cancer Res. 60:2000;4320-4323.
3. Canhoto A.J., Chestukhin A., Litovchick L., DeCaprio J.A. Phosphorylation of the retinoblastoma-related protein p130 in growth-arrested cells. Oncogene. 19:2000;5116-5122.
4. Cavanaugh A.H., Hempel W.M., Taylor L.J., Rogalsky V., Todorov G., Rothblum L.I. Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature. 374:1995;177-180.
5. Connell-Crowley L., Harper J.W., Goodrich D.W. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell. 8:1997;287-301.
6. Dahmus M.E. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271:1996;19009-19012.
7. Darzynkiewicz Z., Traganos F. Multiparameter flow cytometry in studies of the cell cycle. Melamed M., Lidmo T., Mendelsohn M. Flow Cytometry and Sorting. 1990;469 Wiley-Liss, New York, NY.
8. Dowdy S.F., Hinds P.W., Louie K., Reed S.I., Arnold A., Weinberg R.A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell. 73:1993;499-511.
9. Ezhevsky S.A., Nagahara H., Vocero-Akbani A.M., Gius D.R., Wei M.C., Dowdy S.F. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. USA. 94:1997;10699-10704.
10. Farkas T., Hansen K., Holm K., Lukas J., Bartek J. Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4. J. Biol. Chem. 277:2002;26741-26752.
11. Geng Y., Whoriskey W., Park M.Y., Bronson R.T., Medema R.H., Li T., Weinberg R.A., Sicinski P. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell. 97:1999;767-777.
12. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell. 98:1999;859-869.
13. Herman P.K. Stationary phase in yeast. Curr. Opin. Microbiol. 5:2002;602-607.
14. Hinds P.W., Mittnacht S., Dulic V., Arnold A., Reed S.I., Weinberg R.A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 70:1992;993-1006.
15. Hurford R.K. Jr., Cobrinik D., Lee M.H., Dyson N. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1997;1447-1463.
16. Knudsen E.S., Wang J.Y. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271:1996;8313-8320.
17. Kuchin S., Yeghiayan P., Carlson M. Cyclin-dependent protein kinase and cyclin homologs SSN3 and SSN8 contribute to transcriptional control in yeast. Proc. Natl. Acad. Sci. USA. 92:1995;4006-4010.
18. Ladd A.C., Pyatt R., Gothot A., Rice S., McMahel J., Traycoff C.M., Srour E.F. Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0. Blood. 90:1997;658-668.
19. Lajtha, L. (1963). On the concept of cell cycle. J Cell Comp. Physiol. 62 (Suppl 1, pt II), 143-145.
20. Lea N.C., Orr S.J., Stoeber K., Williams G.H., Lam E.W., Ibrahim M.A., Mufti G.J., Thomas N.S. Commitment point during G0 - >G1 that controls entry into the cell cycle. Mol. Cell. Biol. 23:2003;2351-2361.
21. Leclerc V., Tassan J.P., O'Farrell P.H., Nigg E.A., Leopold P. Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II. Mol. Biol. Cell. 7:1996;505-513.
22. Leopold P., O'Farrell P.H. An evolutionarily conserved cyclin homolog from Drosophila rescues yeast deficient in G1 cyclins. Cell. 66:1991;1207-1216.
23. Lew D.J., Dulic V., Reed S.I. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell. 66:1991;1197-1206.
24. Liao S.M., Zhang J., Jeffery D.A., Koleske A.J., Thompson C.M., Chao D.M., Viljoen M., van V.H., Young R.A. A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature. 374:1995;193-196.
25. Liu Z.J., Tanaka Y., Mine S., Morinobu A., Yagita H., Okumura K., Taniguchi T., Yamamura H., Minami Y. Functional cooperation of cyclin C and c-Myc in mediating homotypic cell adhesion via very late antigen-4 activation and vascular cell adhesion molecule-1 induction. Blood. 92:1998;4700-4711. a.
26. Liu Z.J., Ueda T., Miyazaki T., Tanaka N., Mine S., Tanaka Y., Taniguchi T., Yamamura H., Minami Y. A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc. Mol. Cell. Biol. 18:1998;3445-3454. b.
27. Matsushime H., Quelle D.E., Shurtleff S.A., Shibuya M., Sherr C.J., Kato J.Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:1994;2066-2076.
28. Mayol X., Garriga J., Grana X. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene. 11:1995;801-808.
29. Mayol X., Garriga J., Grana X. G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. Oncogene. 13:1996;237-246.
30. Meyerson M., Enders G.H., Wu C.L., Su L.K., Gorka C., Nelson C., Harlow E., Tsai L.H. A family of human cdc2-related protein kinases. EMBO J. 11:1992;2909-2917.
31. Moberg K., Starz M.A., Lees J.A. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1996;1436-1449.
32. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:1992;961-971.
33. Pan W., Sun T., Hoess R., Grafstrom R. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex. Carcinogenesis. 19:1998;765-769.
34. Pardee A.B. G1 events and regulation of cell proliferation. Science. 246:1989;603-608.
35. Rickert P., Seghezzi W., Shanahan F., Cho H., Lees E. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene. 12:1996;2631-2640.
36. Sage J., Miller A.L., Perez-Mancera P.A., Wysocki J.M., Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature. 424:2003;223-228.
37. Sardet C., Vidal M., Cobrinik D., Geng Y., Onufryk C., Chen A., Weinberg R.A. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA. 92:1995;2403-2407.
38. Serizawa H., Makela T.P., Conaway J.W., Conaway R.C., Weinberg R.A., Young R.A. Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature. 374:1995;280-282.
39. Sherr C.J. The Pezcoller lecture. cancer cell cycles revisited Cancer Res. 60:2000;3689-3695.
40. Smith D.B., Johnson K.S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 67:1988;31-40.
41. Sugimoto M., Kuo M.L., Roussel M.F., Sherr C.J. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol. Cell. 11:2003;415-424.
42. Tassan J.P., Jaquenoud M., Léopold P., Schultz S.J., Nigg E.A. Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc. Natl. Acad. Sci. USA. 92:1995;8871-8875.
43. Trimarchi J.M., Lees J.A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3:2002;11-20.
44. Tsutsui T., Hesabi B., Moons D.S., Pandolfi P.P., Hansel K.S., Koff A., Kiyokawa H. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol. Cell. Biol. 19:1999;7011-7019.
45. van den Heuvel S., Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:1993;2050-2054.
46. White R.J., Trouche D., Martin K., Jackson S.P., Kouzarides T. Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature. 382:1996;88-90.
47. Ye X., Zhu C., Harper J.W. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc. Natl. Acad. Sci. USA. 98:2001;1682-1686.
48. Zhang Y.J., Rutledge B.J., Rollins B.J. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis J. Biol. Chem. 269:1994;15918-15924.